ARKEMA/S (OTCMKTS:ARKAY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports.
According to Zacks, “Arkema SA is engaged in the manufacturing and marketing of vinyl products, industrial chemicals, and performance products. Vinyl products include chlorine or caustic soda, pipes and profiles, PVC, and vinyl compounds. Industrial chemicals include emulsion systems, fluorochemicals, hydrogen peroxide, PMMA and methacrylics, specialty acrylic polymers and thiochemicals. Performance products include functional additives, specialty chemicals and technical polymers. The Company’s products can be used for various purposes including air conditioning or refrigeration; chemical processing, coating, construction; packaging; automotive & transportation. Its products, also find their application in adhesives and sealants, agriculture & agrochemicals, consumer goods, electronics, foams, solvents and aerosols market, health, hygiene & beauty, oil & gas, energy, pharmaceuticals, pulp & paper, rubber market, sports & leisure, etc. Arkema SA is headquartered in France. “
A number of other research firms have also recently commented on ARKAY. Morgan Stanley restated an “overweight” rating on shares of ARKEMA/S in a research note on Monday, July 13th. JPMorgan Chase & Co. restated an “overweight” rating on shares of ARKEMA/S in a research note on Tuesday. UBS Group restated a “neutral” rating on shares of ARKEMA/S in a research note on Monday, August 3rd. Finally, Credit Suisse Group restated an “outperform” rating on shares of ARKEMA/S in a research note on Friday, June 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. ARKEMA/S currently has an average rating of “Hold” and a consensus price target of $116.00.
ARKAY opened at $106.01 on Thursday. ARKEMA/S has a one year low of $48.89 and a one year high of $108.19. The stock has a market capitalization of $8.22 billion, a PE ratio of 18.25, a P/E/G ratio of 11.33 and a beta of 1.58. The business’s 50 day moving average price is $98.98 and its 200 day moving average price is $87.78. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.57 and a current ratio of 2.10.
ARKEMA/S (OTCMKTS:ARKAY) last released its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.44 EPS for the quarter. ARKEMA/S had a return on equity of 8.36% and a net margin of 5.05%. The firm had revenue of $2.30 billion for the quarter. As a group, equities research analysts forecast that ARKEMA/S will post 6.18 earnings per share for the current fiscal year.
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. It operates through three segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, poly-ether-ketone-ketone polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals.
Featured Story: Dividend Kings
Get a free copy of the Zacks research report on ARKEMA/S (ARKAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ARKEMA/S Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ARKEMA/S and related companies with MarketBeat.com’s FREE daily email newsletter.